AKAN vs. SMFL, TCBP, SCNI, BBLG, EVLO, SPRC, EVFM, ACOR, VRAX, and NMTR
Should you be buying Akanda stock or one of its competitors? The main competitors of Akanda include Smart for Life (SMFL), TC Biopharm (TCBP), Scinai Immunotherapeutics (SCNI), Bone Biologics (BBLG), Evelo Biosciences (EVLO), SciSparc (SPRC), Evofem Biosciences (EVFM), Acorda Therapeutics (ACOR), Virax Biolabs Group (VRAX), and 9 Meters Biopharma (NMTR). These companies are all part of the "medical" sector.
Smart for Life (NASDAQ:SMFL) and Akanda (NASDAQ:AKAN) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, community ranking, dividends and earnings.
Akanda has a net margin of 0.00% compared to Akanda's net margin of -188.32%.
Smart for Life has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Akanda has a beta of 1.6, meaning that its stock price is 60% more volatile than the S&P 500.
28.4% of Smart for Life shares are owned by institutional investors. Comparatively, 1.0% of Akanda shares are owned by institutional investors. 31.7% of Smart for Life shares are owned by company insiders. Comparatively, 20.4% of Akanda shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
In the previous week, Smart for Life had 13 more articles in the media than Akanda. MarketBeat recorded 13 mentions for Smart for Life and 0 mentions for Akanda. Akanda's average media sentiment score of 0.24 beat Smart for Life's score of 0.00 indicating that Smart for Life is being referred to more favorably in the media.
Akanda has lower revenue, but higher earnings than Smart for Life.
Smart for Life received 1 more outperform votes than Akanda when rated by MarketBeat users.
Summary
Smart for Life beats Akanda on 7 of the 11 factors compared between the two stocks.
Get Akanda News Delivered to You Automatically
Sign up to receive the latest news and ratings for AKAN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AKAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
